Cite
Redecke V, Tawaratsumida K, Larragoite ET, et al. A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation. Sci Rep. 2021;11(1):24507doi: 10.1038/s41598-021-04298-1.
Redecke, V., Tawaratsumida, K., Larragoite, E. T., Williams, E. S. C. P., Planelles, V., Spivak, A. M., Hirayama, L., Elgort, M., Swenson, S., Smith, R., Worthen, B., Zimmerman, R., Slev, P., Cahoon, B., Astill, M., & Häcker, H. (2021). A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation. Scientific reports, 11(1), 24507. https://doi.org/10.1038/s41598-021-04298-1
Redecke, Vanessa, et al. "A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation." Scientific reports vol. 11,1 (2021): 24507. doi: https://doi.org/10.1038/s41598-021-04298-1
Redecke V, Tawaratsumida K, Larragoite ET, Williams ESCP, Planelles V, Spivak AM, Hirayama L, Elgort M, Swenson S, Smith R, Worthen B, Zimmerman R, Slev P, Cahoon B, Astill M, Häcker H. A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation. Sci Rep. 2021 Dec 30;11(1):24507. doi: 10.1038/s41598-021-04298-1. PMID: 34969960; PMCID: PMC8718524.
Copy
Download .nbib